NexBio Inc. is a fast growing biopharmaceutical company dedicated to create and commercialize novel, broad-spectrum biopharmaceuticals to prevent and treat current and emerging life-threatening human disease.
We have an immediate need for a Post-Doctoral Scientist to work in the area of protein purification process development. We are looking for an individual with passion for science, proactive attitude, and ability to multitask and work as part of a small dedicated team. The candidate will have an opportunity to learn the recombinant protein purification development steps and strategies that are necessary to translate into successful commercial scale manufacturing processes. Candidates are required to have a Ph.D. in a biological, biochemical, chemical, chemical engineering or bioengineering field. The successful candidate should have very strong experience in protein purification and characterization. A strong record of past achievements (publications in peer-reviewed journals) is preferred.
NexBio focuses on the treatment of diseases through distinct host-targeting mechanisms of action. Fludase, a novel broad-spectrum recombinant protein for the prophylaxis and treatment of Influenza-Like Illness caused by all influenza and parainfluenza viruses, as well as pandemic influenza caused by strains such as H5N1, has recently completed a First-In-Man clinical trial. Viradin, at lead optimization stage, is directed to the treatment of viral hemorrhagic fever caused by viruses such as Ebola, as well as sepsis and septic shock. TOSAP a microparticle formulation technology invented at NexBio, is offered as a service and technology licensing business to third parties, as well as a source of internal pipeline development. As the world faces the mounting threats from an influenza pandemic and from other bioterror agents, NexBios therapeutic programs have enjoyed very generous government funding and high levels of public interest. NexBio is looking for highly motivated, dedicated, and competent individuals to strengthen our team.
NexBio is an equal-opportunity employer. The company operates according to the following philosophy:
We focus on important medical problems
We are dedicated to translating scientific knowledge into clinical therapy for the public good
We build a team with common goals, solid values, and high competency
We nurture open communication, personal growth, and professional development
We strive for cost-effectiveness on a daily basis
This position offers ample opportunity for career development. NexBio offers competitive salary, attractive stock options, and full benefits. Current work authorization in USA is required. Relocation will not be offered with this position. Southern California applicants only please. For consideration, send your resume and a concise e-mail cover letter describing your qualifications to hr@nexbio.com.
We have an immediate need for a Post-Doctoral Scientist to work in the area of protein purification process development. We are looking for an individual with passion for science, proactive attitude, and ability to multitask and work as part of a small dedicated team. The candidate will have an opportunity to learn the recombinant protein purification development steps and strategies that are necessary to translate into successful commercial scale manufacturing processes. Candidates are required to have a Ph.D. in a biological, biochemical, chemical, chemical engineering or bioengineering field. The successful candidate should have very strong experience in protein purification and characterization. A strong record of past achievements (publications in peer-reviewed journals) is preferred.
NexBio focuses on the treatment of diseases through distinct host-targeting mechanisms of action. Fludase, a novel broad-spectrum recombinant protein for the prophylaxis and treatment of Influenza-Like Illness caused by all influenza and parainfluenza viruses, as well as pandemic influenza caused by strains such as H5N1, has recently completed a First-In-Man clinical trial. Viradin, at lead optimization stage, is directed to the treatment of viral hemorrhagic fever caused by viruses such as Ebola, as well as sepsis and septic shock. TOSAP a microparticle formulation technology invented at NexBio, is offered as a service and technology licensing business to third parties, as well as a source of internal pipeline development. As the world faces the mounting threats from an influenza pandemic and from other bioterror agents, NexBios therapeutic programs have enjoyed very generous government funding and high levels of public interest. NexBio is looking for highly motivated, dedicated, and competent individuals to strengthen our team.
NexBio is an equal-opportunity employer. The company operates according to the following philosophy:
We focus on important medical problems
We are dedicated to translating scientific knowledge into clinical therapy for the public good
We build a team with common goals, solid values, and high competency
We nurture open communication, personal growth, and professional development
We strive for cost-effectiveness on a daily basis
This position offers ample opportunity for career development. NexBio offers competitive salary, attractive stock options, and full benefits. Current work authorization in USA is required. Relocation will not be offered with this position. Southern California applicants only please. For consideration, send your resume and a concise e-mail cover letter describing your qualifications to hr@nexbio.com.
No comments:
Post a Comment